Psychedelic Health UK report In what marks an important development for Europe, a number of EU bodies have published a joint commentary in the world-leading medical...
Marijuana Moment Hawaii senators have approved a bill in committee to promote research into the therapeutic potential of psilocybin, MDMA and other alternative treatments for mental...
Patent application covers use of novel homing peptides to reduce toxicity and advance payload of therapeutic ENGLEWOOD CLIFFS, NJ, Feb. 13, 2023 (GLOBE NEWSWIRE) — Silo...
A West Australian teacher caught with MDMA and magic mushrooms following a police investigation into drug-laced lollipops at his son’s school has been banned from teaching...
Green Party Leader Elizabeth May wants Canada to consider expanding access to psychedelics as medical treatments. May was among the MPs who joined a delegation of...
Marijuana Moment reports Arizona lawmakers have approved a bill in committee to promote research into the medical potential of psilocybin mushrooms for a variety of conditions, which could...
CAMH will study PEX010, Filament’s botanical psilocybin drug candidate, in a Health Canada-approved clinical trial for mild cognitive impairment VANCOUVER, BC, Feb. 14, 2023 /CNW/ – Filament Health Corp. (OTCQB:...
It looks like a pill, and it tastes just like one…but this isn’t your typical over-the-counter medication. Leading the charge in natural drug development, Vancouver-basedFilament Healthis...
The Case for Microdosing: Why Legalization Matters In a recent episode of the Third Wave Podcast, Vicente LLP founding partner Josh Kappel joined Ali Schaper, CEO and co-founder of...
The Therapeutic Goods Administration (TGA) has announced that Psilocybin and MDMA will be able to be prescribed by specially qualified psychiatrists for the treatment of particular...
